BIOAGE LABS INC (BIOA) Stock Analyst Earnings Estimates
NASDAQ:BIOA - Nasdaq - US09077V1008 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A -33.35% | N/A -0.12% | ||||
| EBITDA YoY % growth | -39.84M | -48.238M -21.08% | -78.027M -61.75% | N/A -20.60% | N/A -22.23% | N/A -12.06% | |
| EBIT YoY % growth | -39.969M | -48.4M -21.09% | -78.194M -61.56% | N/A 8.80% | N/A -18.08% | N/A -12.54% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A 76.03% | N/A -16.65% | N/A -3.20% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.49 | -0.53 92.13% | -0.58 70.45% | -0.36 0.83% |
| Revenue Q2Q % growth | 591.6K | 591.6K | 591.6K | N/A |
| EBITDA Q2Q % growth | -18.882M 32.56% | -19.545M 20.64% | -20.238M 19.68% | N/A |
| EBIT Q2Q % growth | -15.626M 44.35% | -15.946M 35.57% | -16.808M 33.73% | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.36 | -0.54 | 0.18 | 33.23% |
| Q4 2024 Q2Q % growth | -1.97 | -2.12 | 0.15 | 7.10% |
| Q3 2024 Q2Q % growth | -6.70 | -0.74 | -5.96 | -810.10% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 7.82% | 0% | 9.3% |
| Revenue | 0% | N/A | 0% | N/A |